Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Timser SAPI de CV
GI Innovation, Inc.
AstraZeneca
Ensem Therapeutics
Seagen Inc.
N.N. Alexandrov National Cancer Centre
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Pfizer
M.D. Anderson Cancer Center
Basic Health International, Inc.
Kivu Bioscience Inc.
University Hospital Heidelberg
Alterome Therapeutics, Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Duke University
Duke University
Medtronic - MITG
University Health Network, Toronto
M.D. Anderson Cancer Center
University of Chicago
Bayer
National Taiwan University Hospital
Eastern Cooperative Oncology Group
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Saglik Bilimleri Universitesi
Tata Memorial Hospital
Rutgers, The State University of New Jersey
Terremoto Biosciences Inc.
UNC Lineberger Comprehensive Cancer Center
Seoul National University Bundang Hospital
Samsung Medical Center
Bristol-Myers Squibb
Institut Claudius Regaud
Columbia University
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Institut d'Investigació Biomèdica de Bellvitge
University of California, Irvine
Tata Memorial Hospital
Tata Memorial Hospital
Tizona Therapeutics, Inc
Tata Memorial Hospital